← All trials
NCT05251714
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 27, 2022
- Primary completion
- Aug 31, 2025
- Completion date
- Aug 31, 2025
- First posted
- Feb 23, 2022
- Last posted
- Jul 29, 2022
- Enrollment
- 44
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Treadwell Therapeutics, IncLead sponsor
- Ohio State UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.